JMS Co., Ltd. 7702
TSE · Japan · Health Technology
¥448.00-1.00 (-0.22%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Closed System Drug Transfer Devices Market size & share revenue was valued at approximately USD 1.47 Billion in 2025 and is expected to reach USD 1.58 Billion in 2026 and is expected to reach around USD 3.21 Billion by 2035, at a CAGR of 8.3% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are BD (Becton Dic
ProLogium, a global leader in next-generation lithium-ceramic battery technology, today announced that it has formally signed a Memorandum of Understanding (MoU) with Buima Energy Co., Ltd. (a wholly owned subsidiary of Buima group Inc. (TWSE: 5543)), JMS Co., Ltd. (JMS), an advanced battery module manufacturer, and GWA Co., Ltd. (GWA), which focuses on battery application development for electric cargo bikes (e-Cargo Bikes). This four-party strategic alliance brings together leading capabilitie
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.